Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.1384 per EA under NDC 69315091001. Its NADAC has been published 307 times since Aug 12, 2020.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
diphenoxylate hydrochloride and atropine sulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
Leading Pharma, LLCNDC
69315091001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213413On Market Since
3/15/2020
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 307 times since Aug 12, 2020, and over the history we have for it it has declined 47.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1384 per EA |
|---|---|
| All-time high | $0.2788 (Sep 16, 2020) |
| All-time low | $0.1298 (Nov 20, 2024) |
| 52-week high | $0.1840 |
| 52-week low | $0.1384 |
| Median price | $0.1946 |
| Average price | $0.1914 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 307 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by Leading Pharma, LLC, is $0.1384 per EA (NDC 69315091001), effective Jun 24, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 47.2%. It has been tracked across 307 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Aug 12, 2020, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1298 (Nov 20, 2024) to a high of $0.2788 (Sep 16, 2020), with a median of $0.1946 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, but none are currently priced below it.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 69315091001) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification